JPMorgan Chase (JPM) Is Getting Crushed As Investors Worry About Q2 Results
Tweet Send to a Friend
Get Alerts JPM Hot Sheet
Up)
Trade JPM Now!
JPMorgan Chase & Co. (NYSE: JPM) is just getting creamed Thursday as investors are dreading second quarter results due on July 13th.
Trading losses promise to dampen EPS for the quarter and questions are abound about how large the London Whales losses have gotten. First disclosed at $2 billion, losses have grown to $4-$6 billion and maybe even as high a $9 billion.
Although EPS estimates have been ratcheted down 12 percent over the past month, analysts still see the company earning on average of $0.79 per share. This could prove be a high bar to beat considering all the problems.
Piling-on the JPMorgan bandwagon, Meredith Whitney downgraded the stock to Hold on Tuesday.
Shares of JPM last traded down 4 percent, versus a 1.5 percent down move in the Financial Select Sector SPDR (NYSE: XLF).
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Trading losses promise to dampen EPS for the quarter and questions are abound about how large the London Whales losses have gotten. First disclosed at $2 billion, losses have grown to $4-$6 billion and maybe even as high a $9 billion.
Although EPS estimates have been ratcheted down 12 percent over the past month, analysts still see the company earning on average of $0.79 per share. This could prove be a high bar to beat considering all the problems.
Piling-on the JPMorgan bandwagon, Meredith Whitney downgraded the stock to Hold on Tuesday.
Shares of JPM last traded down 4 percent, versus a 1.5 percent down move in the Financial Select Sector SPDR (NYSE: XLF).
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: Vanda Pharmaceuticals (VNDA) Opens Higher; Lazard Raises PT to $17
- Amid Tesla (TSLA) Squeeze, Option Prices Hit Record Highs
- Tableau Software (DATA) IPO indicated $37-$40 after pricing at $31
Create E-mail Alert Related Categories
Trader TalkRelated Entities
JPMorgan, Meredith Whitney
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
